We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleFinal analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer.AuthorsAragon-Ching JB; Jain L; Gulley JL; Arlen PM; Wright JJ; Steinberg SM; Draper D; Venitz J; Jones E; Chen CC; Figg WD; Dahut WLPublicationBJU international, 2009, Vol 103, Issue 12, p1636ISSN1464-410xPublication typearticleDOI10.1111/j.1464-410X.2008.08327.x